As shared above in the story by Dr. Sichel and in the story by Dr. Kim, ELEOTINŽ was initially developed by the scientists at the Julia McFarlane Diabetes Research Center (JMDRC) at the University of Calgary in Alberta, Canada. The JMDRC is a leader in research on the cause, cure, and prevention of Type I and Type II diabetes. After the initial development by the JMDRC, research and development continued on by Eastwood Bio-Medical Research Inc. (EMBR) and other researchers.
Back to Q & A